Rodrigo Arancibia is the Chairman of the Board and Executive Director of CELLUS Group. He is both a Biochemist from Universidad de Chile and an MBA (Master in Business Administration) from Cranfield School of Management, UK. Rodrigo also has a Master in Management and Globalization degree and a Postgraduate Diploma in Project Management, both from Universidad de Chile. He has 14 years of experience in human cell biotechnology and biobusiness. He is the author of 15 international publications in applied subcellular biology and management of research and development projects at the Faculty of Medicine of the Pontificia Universidad Catolica de Chile. Rodrigo is also the General Director of the CORFO project of Business R & D & I Portfolio: “Development of CELLUSPHERES®, innovative product of cell therapy for regeneration tissue based on three-dimensional (3D) spheroids of expanded adult mesenchymal cells (MSCs) with export potential”.